Jonathon Unwin
Stock Analyst at Barclays
(0.15)
# 4,381
Out of 4,491 analysts
52
Total ratings
15.4%
Success rate
-22.5%
Average return
Main Sectors:
Stocks Rated by Jonathon Unwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: AFX Carl Zeiss Meditec AG | Maintained: Hold | €28.00 | $29.16 | -3.98% | 10 | Jul 7, 2026 | |
| SWX: YPSN Ypsomed Holding AG | Maintained: Buy | CHF 386.00 | $351.20 | +9.91% | 6 | Jun 25, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Maintained: Hold | €16.00 | $17.34 | -7.73% | 12 | May 13, 2026 | |
| ETR: GXI Gerresheimer AG | Downgraded: Sell | €23.00 → €19.00 | $29.14 | -34.80% | 7 | Apr 28, 2026 | |
| STO: VIMIAN Vimian Group AB (publ) | Maintained: Sell | kr 25.00 | $29.95 | -16.53% | 11 | Mar 27, 2026 | |
| LON: ONT Oxford Nanopore Technologies plc | Maintained: Buy | 127p → 172p | $114.40 | +50.35% | 6 | Mar 25, 2026 |
Carl Zeiss Meditec AG
Jul 7, 2026
Maintained: Hold
Price Target: €28.00
Current: $29.16
Upside: -3.98%
Ypsomed Holding AG
Jun 25, 2026
Maintained: Buy
Price Target: CHF 386.00
Current: $351.20
Upside: +9.91%
SCHOTT Pharma AG & Co. KGaA
May 13, 2026
Maintained: Hold
Price Target: €16.00
Current: $17.34
Upside: -7.73%
Gerresheimer AG
Apr 28, 2026
Downgraded: Sell
Price Target: €23.00 → €19.00
Current: $29.14
Upside: -34.80%
Vimian Group AB (publ)
Mar 27, 2026
Maintained: Sell
Price Target: kr 25.00
Current: $29.95
Upside: -16.53%
Oxford Nanopore Technologies plc
Mar 25, 2026
Maintained: Buy
Price Target: 127p → 172p
Current: $114.40
Upside: +50.35%